Tiotropium Appears to Cut Deaths, Cardiovascular Event Rates

MedPage Today -- Patients taking tiotropium bromide (Spiriva) for chronic obstructive pulmonary disease (COPD) appear to be at decreased risk for death and cardiovascular events compared with placebo, researchers said.